Literature DB >> 21709806

Clinical Approach to the Treatment of Painful Diabetic Neuropathy.

Alexandra Hovaguimian1, Christopher H Gibbons.   

Abstract

Painful neuropathy is a common and often progressive complication of diabetes. Patients frequently report symptoms of tingling, burning, lancinating pain, hyperesthesia and allodynia. The natural history of the disease may vary from intermittent mild symptoms to severe chronic daily pain; the latter is often associated with diminished quality of life. There are a variety of pharmaceutical agents from different medicinal categories available for the symptomatic treatment of painful diabetic neuropathy, however selecting an agent is often challenging given the breadth of choices and lack of consistent guidelines. As a result, many patients remain untreated or undertreated.This article presents a practical clinical approach to the treatment of pain in diabetic neuropathy. Recommendations for first, second and third line medications are based on specific evidence for the treatment of painful diabetic neuropathy as well as safety, tolerability, drug interactions and cost. Additional topics of discussion include breakthrough pain, opioid use and topical therapies. This review does not comprehensively discuss all possible treatments for painful neuropathy, but provides a systematic approach designed to guide clinicians in tailoring therapies to the individual patient.

Entities:  

Year:  2011        PMID: 21709806      PMCID: PMC3119492          DOI: 10.1177/2042018810391900

Source DB:  PubMed          Journal:  Ther Adv Endocrinol Metab        ISSN: 2042-0188            Impact factor:   3.565


  85 in total

1.  Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy.

Authors:  Christopher H Gibbons; Roy Freeman
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

2.  A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

Authors:  J F Wernicke; Y L Pritchett; D N D'Souza; A Waninger; P Tran; S Iyengar; J Raskin
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

3.  Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation.

Authors:  M Nolano; D A Simone; G Wendelschafer-Crabb; T Johnson; E Hazen; W R Kennedy
Journal:  Pain       Date:  1999-05       Impact factor: 6.961

4.  Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial.

Authors:  S H Sindrup; F W Bach; C Madsen; L F Gram; T S Jensen
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

5.  Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.

Authors:  M B Max; S A Lynch; J Muir; S E Shoaf; B Smoller; R Dubner
Journal:  N Engl J Med       Date:  1992-05-07       Impact factor: 91.245

6.  Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy.

Authors:  F J Gómez-Pérez; R Choza; J M Ríos; A Reza; E Huerta; C A Aguilar; J A Rull
Journal:  Arch Med Res       Date:  1996       Impact factor: 2.235

7.  Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives.

Authors:  Mugdha Gore; Nancy A Brandenburg; Deborah L Hoffman; Kei-Sing Tai; Brett Stacey
Journal:  J Pain       Date:  2006-12       Impact factor: 5.820

8.  A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.

Authors:  Che S Zin; Lisa M Nissen; James P O'Callaghan; Stephen B Duffull; Maree T Smith; Brendan J Moore
Journal:  J Pain       Date:  2009-12-03       Impact factor: 5.820

9.  Topical capsaicin in painful diabetic neuropathy. Controlled study with long-term follow-up.

Authors:  R Tandan; G A Lewis; P B Krusinski; G B Badger; T J Fries
Journal:  Diabetes Care       Date:  1992-01       Impact factor: 19.112

10.  Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial.

Authors:  J A Rull; R Quibrera; H González-Millán; O Lozano Castañeda
Journal:  Diabetologia       Date:  1969-08       Impact factor: 10.122

View more
  9 in total

1.  Evaluation of Effect of Nishamalaki on STZ and HFHF Diet Induced Diabetic Neuropathy in Wistar Rats.

Authors:  Jayshree Shriram Dawane; Vijaya Anil Pandit; Madhura Shirish Kumar Bhosale; Pallawi Shashank Khatavkar
Journal:  J Clin Diagn Res       Date:  2016-10-01

2.  Pilot Study of Exercise Therapy on Painful Diabetic Peripheral Neuropathy.

Authors:  Min Yoo; Linda J D'Silva; Katherine Martin; Neena K Sharma; Mamatha Pasnoor; Joseph W LeMaster; Patricia M Kluding
Journal:  Pain Med       Date:  2015-03-20       Impact factor: 3.750

3.  Bioanalytical methods for the detection of duloxetine and thioctic acid in plasma using ultra performance liquid chromatography with tandem mass spectrometry (UPLC-MS/MS).

Authors:  Zhuodu Wei; Hyeon-Cheol Jeong; Ye-Ji Kang; Jaesang Jang; Myoung-Hwan Kim; Kwang-Hee Shin
Journal:  Transl Clin Pharmacol       Date:  2022-06-15

4.  Quercetin protects rat dorsal root ganglion neurons against high glucose-induced injury in vitro through Nrf-2/HO-1 activation and NF-κB inhibition.

Authors:  Yue Shi; Xiao-chun Liang; Hong Zhang; Qun-li Wu; Ling Qu; Qing Sun
Journal:  Acta Pharmacol Sin       Date:  2013-06-17       Impact factor: 6.150

5.  Adding pregabalin or gabapentin for the management of community-treated patients with painful diabetic peripheral neuropathy: a comparative cost analysis.

Authors:  Antoni Sicras; Javier Rejas; Ruth Navarro; Albert Planas
Journal:  Clin Drug Investig       Date:  2013-11       Impact factor: 2.859

6.  A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine.

Authors:  Jeffrey J Ellis; Alesia B Sadosky; Laura L Ten Eyck; Pallavi Mudumby; Joseph C Cappelleri; Lilian Ndehi; Brandon T Suehs; Bruce Parsons
Journal:  BMC Health Serv Res       Date:  2015-04-15       Impact factor: 2.655

7.  Painful Diabetic Peripheral Neuropathy: Presentations, Mechanisms, and Exercise Therapy.

Authors:  Min Yoo; Neena Sharma; Mamatha Pasnoor; Patricia M Kluding
Journal:  J Diabetes Metab       Date:  2013-06-30

8.  Micronized palmitoylethanolamide reduces the symptoms of neuropathic pain in diabetic patients.

Authors:  Chiara Schifilliti; Lelio Cucinotta; Viviana Fedele; Carmela Ingegnosi; Salvatore Luca; Carmelo Leotta
Journal:  Pain Res Treat       Date:  2014-04-02

9.  The Need for Improved Management of Painful Diabetic Neuropathy in Primary Care.

Authors:  Teresa Sobhy
Journal:  Pain Res Manag       Date:  2016-03-02       Impact factor: 3.037

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.